|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Dr. Paul S. Blunden M.D.||Pres, Director, Medical Advisor & CFO||N/D||N/D||N/D|
|Mr. Philip Bendick Ph.D.||Medical Advisor & Independent Board Director||N/D||N/D||N/D|
|Mr. Darren Day||Chief Exec. Officer||N/D||N/D||N/D|
|Mr. Alan Langston||VP of Sales & Marketing||N/D||N/D||N/D|
|Dr. Orville Day||Lead Physicist||N/D||N/D||N/D|
|Mr. Erwin Wong B.Com.||Strategic Financial Consultant||N/D||N/D||1968|
|Mr. Jeremy Poirier||Consultant||N/D||N/D||1986|
CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.
L'ISS Governance QualityScore di CVR Medical Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.